Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function.

Lancet (London, England) - 8 Mar 2014

Massie John, Castellani Carlo, Grody Wayne W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator
Share to CFTR gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Carrier Screening

Share to Molecular Targeted Therapy

Share to Mutation

Share to Quinolones

Source

Identifiers

PMID: 23992917
DOI: 10.1016/S0140-6736(13)61092-2

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function.PMID 23992917Read ↗

Applying CFTR molecular genetics to facilitate the diagnosis of cystic fibrosis through screening.Semantic proximity Read ↗

Advances in the diagnosis and treatment of cystic fibrosis.Semantic proximity Read ↗

Updated recommendations for CFTR carrier screening: A position statement of the American College of Medical Genetics and Genomics (ACMG).Semantic proximity Read ↗

Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians.Semantic proximity Read ↗

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators.Semantic proximity Read ↗

A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.Semantic proximity Read ↗

Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.Semantic proximity Read ↗

Emerging medicines to improve the basic defect in cystic fibrosis.Semantic proximity Read ↗

Expanding CFTR Modulator Testing to Carriers of CFTR Variants.Semantic proximity Read ↗

Treatment of cystic fibrosis based on understanding CFTR.Semantic proximity Read ↗

Progress towards next-generation therapeutics for cystic fibrosis.Semantic proximity Read ↗

Carrier screening for cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.